Conférences - Législation en médecine et pharmacologie

PRA Consultancy

This course will provide attendees with essential knowledge and practices to develop their PV expertise. The attendees will be trained by PV experts within and outside the pharmaceutical industry.

PRA Training Department;     Tél.: [00971543065737];     Email.: training@pra-me.com

Pharmacovigilance, PV, GCC, Certification, drug safety, patient safety, pharmacy, pharmaceuticals

Virtue Insight

Join 5th Annual Pharma Regulatory Summit 2022 to discuss multi-regional cooperation, global harmonization and best practices related to India’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure certainty in India and strategic initiatives to improve collaboration and cooperation.

Tél.: [9361957193];     Email.: kavitha@virtueinsight.co.in

Regulatory Affairs, Regulatory Writing, Medical Writing, Publishing, Submissions, scientific writing

Hubplus Events

GCC Regulatory Affairs Pharma Summit is an annual event that provides platform for pharmaceutical regulatory experts and industry professionals in the GCC region to share insights and discuss about the latest updates in the pharmaceutical regulations. This Summit is one of the first and strategic meeting place in the GCC region for local and international pharmaceutical and medical industry professionals to meet and discuss on topics related to all aspects of regulatory affairs, legal and compliance.

Marketing Manager;     Tél.: [971 4 299 9398];     Email.: rabie@hubplus-events.com

regulatory affairs, pharmaceuticals, medical device, medical device registration

SMi Group

Navigating the challenges and legal landscapes of parallel trade

SMi presents its 16th annual Parallel Trade virtual conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

The 2022 event will be more significant than ever before due to the transition period after Brexit coming to an end. As such, the UK will no longer be part of the EU free market. This will mean increased medicines prices, reduced access to some specialist drugs and greater risk of supply chain shortages. In a post-Brexit environment, exhaustion of rights will cease to apply to the UK, making import and export a costly business and in a worst-case scenario could effectively kill parallel distribution.

This conference will bring together industry experts to discuss the challenges and drivers of the industry, including the EU regulatory landscape and the impact of the Brexit and the Pandemic together. The conference will also provide global insights on Parallel trade and will reflect on key takeaways for other member states.

Tél.: [+442078276088];     Email.: Rjones@smi-online.co.uk

Parallel Trade, Pharmaceutical Trade, Pharmaceutical Logistics, Pharmaceutical regulation, Pharmaceutical distribution